41/163US=14 / Dermatologia
Storey A, Simmonds M. Interaction between ultraviolet radiation and human papillomavirus. In: Ulrich ESC, Euvrard S, Proby C, Bavinck JNB, Geissler EK. Skin cancer after organ transplantation. New York: Springer, 2009. p. 159-67. (Cancer Treatment and Reseach) ISBN 978-0-387-78573-8.

RADIACAO ULTRAVIOLETA; VIRUS DO PAPILOMA HUMANO; HPV; APOPTOSE; REGULACAO DO CICLO CELULAR; P53; BAK; BAX


42/163US=16 / Câncer
Rathi AV, Pipas JM. Oncogenic transformation by polyomavirus large T antigen. In: Khalili K, Jeang KT. Viral oncology: basic science and clinical applications. New Jersey: Wiley-Blackwell, 2010. p. 149-64. ISBN 978-0-470-37991-2.

CANCER; TRANSFORMACAO ONCOGENICA; ANTIGENO T; POLIOMAVIRUS; P53; TAG


43/163US=16 / Estatística
Xu XC. Risk factors and gene expression in esophageal cancer. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 335-60. (Methods in Molecular Biology, 471) ISBN 978-1-58829-987-1.

CANCER DE ESOFAGO; FATORES DE RISCO; EXPRESSAO GENICA; TABAGISMO; ALCOOLISMO; REFLUXO GASTROESOFAGICO; ALTERACOES GENETICAS; CANCER. PREVENCAO; ESOFAGO DE BARRET; ADENOCARCINOMA ESOFAGICO; MUTACAO DO GENE P53; ALTERACAO DO GENE P16; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMAL (EGFR); CADERINA-E; COX-2; QUIMIOPREVENCAO; ACIDOS RETINOICOS; ANTI-INFLAMATORIOS NAO ESTEROIDES; EGCG; CURCUMINA


44/163US=35 / Gastro
Smith RC. Novel biomarkers for biliary tract cancer. In: Thomas CR Junior, Fuller CD. Biliary tract and gallbladder cancer: diagnosis and therapy. New Jersey: DemosMedical, 2009. p. 65-76. ISBN 978-1-933864-42-6.

CANCER DO TRATO BILIAR; BIOMARCADORES; COLANGIOCARCINOMA; P53; ATIVADOR DE PLASMINOGENIO UROQUINASE; INIBIDOR DO ATIVADOR DO PLASMINOGENIO TIPO 2; ANALISE PROTEOMICA DA BILE


45/163US=45 / Biol/Mol
Kondoh H. The role of glycolysis in cellular immortalization. In: Apte SP, Sarangarajan R, editors. Cellular respiration and carcinogenesis. New Jersey: Humana Press, 2009. p. 91-102. ISBN 978-1-934115-07-7.

P53; PAPEL DA GLICOLISE EM IMORTALIZACAO CELULAR; FOSFOGLICERATO MUTASE; GLICOLISE; EFEITO WARBURG


46/163US=45 / Biol/Mol
Gonzalez-Cuyar LF, Tavora F, Caminha I, Perry G, Smith MA, Castellani RJ. Cellular respiration and tumor suppressor genes. In: Apte SP, Sarangarajan R, editors. Cellular respiration and carcinogenesis. New Jersey: Humana Press, 2009. p. 131-44. ISBN 978-1-934115-07-7.

P53; RESPIRACAO CELULAR; TUMOR SUPRESSOR; VON HIPPEL LINDAU; RESPIRACAO CELULAR; GENES SUPRESSORES DE TUMOR; HIPOXIA FATORES INDUZIVEIS


47/163US=60 / Biol/Mol
Redondo M, Fúnez R, Esteban F. Apoptosis in the development and treatment of laryngeal cancer: role of p53, Bcl-2 and clusterin. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 237-49. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; CANCER DE LARINGE; P53; BCL-2; CLUSTERINA


48/163US=60 / Biol/Mol
Dinnen RD, Petrylak DP, Fine RL. Strategies to circumvent resistance to apoptosis in prostate cancer cells by targeted necrosis. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 327-46. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; RESISTENCIA A APOPTOSE; CANCER DE PROSTATA; NECROSE; P53; ESPECIES REATIVAS DE OXIGENIO


49/163US=64 / Biol/Mol
Corcoran CA, Huang Y, Sheikh MS. Energy generating pathways and the tumor suppressor p53. In: Singh KK, Costello LC. Mitochondria and cancer. New York: Spriger, 2009. p. 131-50. ISBN 978-0-387-84834-1.

ENERGIA VIAS GERADORAS; SUPRESSOR TUMORAL P53; REGULACAO DE PROTEINAS ENVOLVIDAS NA GLICOLISE POR 53; REGULACAO DAS PROTEINAS ENVOLVIDAS NA RESPIRACAO AEROBIA POR 53


50/163US=85 / Biol/Mol
Sitorus RS, Gumay S, Valk PVD. The apoptotic paradox in retinoblastoma. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 77-93. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

PROLIFERACAO; APOPTOSE; INDICE MITOTICO; INDICE APOPTOTICO; MIB-1; CASPASE; CASPASE-3; RECEPTOR FAS; P53; RETINOBLASTOMA


51/163US=85 / Biol/Mol
Sulkowski S, Wincewicz A, Sulkowska M, Koda M. Transforming growth factor-&*946;1 and regulators of apoptosis: p53, bax, and Bcl-xL in colorectal cancers. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 116-23. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

TGF-&*946;1; P53; BAX; BCL-XL; PROGRESSAO DO CANCER COLORRETAL; CELULAS INFLAMATORIAS; IMUNOSSUPRESSAO


52/163US=85 / Biol/Mol
Kim DH, Kim EH, Na HK, Surh YJ. Effects of 15-deoxy-&*916; 12,14-prostaglandin J² on the expression of p53 in MCF-7 cells. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 202-9. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

15-DESOXI-&*916; J² 12,14-PROSTAGLANDINA; P53; CELULAS HUMANAS DE CANCER DE MAMA; MCF-7 CELULAS


53/163US=85 / Biol/Mol
Song NY, Kim DH, Kim EH, Na HK, Surh YJ. 15-Deoxy-&*916; 12,14-prostaglandin J² induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 210-6. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

15-DESOXI-&*916; J² 12,14-PROSTAGLANDINA; P53; MULTIRRESISTENCIA PROTEINA ASSOCIADA 1; CELULAS HUMANAS DE CANCER DE MAMA


54/163US=85 / Biol/Mol
Wesierska-Gadek J, Krystof V. Selective cyclin-dependent kinase inhibitors discriminating between cell cycle and transcriptional kinases: future reality or utopia?. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 228-41. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

CICLO CELULAR; CYC202; CICLINA-QUINASE DEPENDENTE; P53; ROSCOVITINA; TRANSCRICAO


55/163US=85 / Biol/Mol
Wandl S, Wesierska-Gadek J. Is olomoucine, a weak CDK2 inhibitor, able to induce apoptosis in cancer cells?. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 242-9. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

CDKS; G1; FARMACOLOGICA CDK2 INIBIDOR; G1 PRISAO; PARADA DO CICLO CELULAR; SUPRESSOR DE TUMOR P53; APOPTOSE


56/163US=85 / Biol/Mol
Wandl S, Wesierska-Gadek J. Is olomoucine, a weak CDK2 inhibitor, able to induce apoptosis in cancer cells?. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 242-9. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

CDKS; FARMACOLOGICA CDK2 INIBIDOR; SUPRESSOR DE TUMOR P53; APOPTOSE; PRIVACAO DE SORO; PARADA DO CICLO CELULAR


57/163US=85 / Biol/Mol
Kim SY, Kim JE, Lee KW, Lee HJ. Lactococcus lactis ssp. lactis inhibits the proliferation of SNU-1 human stomach cancer arrest and apoptosis via p53 and p21 expression. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 270-5. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

APOPTOSE; G0/G1 PARADA DO CICLO CELULAR; LACTOCOCCUS LACTIS SSP. LACTIS; CANCER DE ESTOMAGO


58/163US=85 / Biol/Mol
Kim MS, Kwon JY, Kang NJ, Lee KW, Lee HJ. Phloretin induces apoptosis in H-Ras MCF10A human breast tumor cells through the activation of p53 via JNK and p38 mitogen-activated protein kinase signaling. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 479-83. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

APOPTOSE; CANCER DE MAMA; JNK; P38 MAPK; FLORETINA


59/163US=85 / Biol/Mol
Lee YK, Hwang JT, Lee MS, Kim YM, Park OJ. Kidney bean husk extracts exrc antitumor effect by inducing apoptosis involving AMP-activated protein kinase signaling pathway. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 484-8. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

CASCA DE FEIJAO; APOPTOSE; AICAR; EFEITOS ANTITUMORAIS; HT-29 DO COLON CELULAS CANCEROSAS; P53 TIPO SELVAGEM


60/163US=85 / Biol/Mol
Lee YK, Park SI, KimYM, Park OJ. Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 489-94. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

APOPTOSE; CURCUMINA; AKT; AMPK; COX-2; PARADA DO CICLO CELULAR; HT-29COLON CELULAS CANCEROSAS; P53 TIPO SELVAGEM


Primeira | Anterior | Próxima | Última